Invasive mucormycosis in post COVID-19 infection: Case report with review

Sunil V Jagtap; Swati S Jagtap; Vaidehi Nagar; Kaushiki Varshney

doi:10.18231/j.achr.2021.033

journal article May 15, 2021

Invasive mucormycosis in post COVID-19 infection: Case report with review

Sunil V Jagtap Swati S Jagtap Vaidehi Nagar Kaushiki Varshney

IP Archives of Cytology and Histopathology Research Vol. 6 No. 2 pp. 135-139 · IP Innovative Publication Pvt Ltd

View at Publisher Save 10.18231/j.achr.2021.033

Abstract

COVID-19 is an infection caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Now there are increased cases with super infections by mucormycosis, which were rarely reported in the beginning of the current pandemic of COVID 19. Herewith a case of 47 year-old male patient of post COVID-19 infection having severe hypoxia and was on ventilator, received steroid treatment and also known case of HIV/AIDS. Now admitted to our hospital having fever, facial pain, and swelling mid-face region. His RT-PCR test was positive. On clinical, radio imaging and on histopathological findings diagnosed as maxillary mucormycosis. We are presenting this rare case for its clinical, radio imaging, and on histopathological findings.

Topics

No keywords indexed for this article. Browse by subject →

References

22

[1]

Park M, Cook AR, Lim JT, Sun Y, Dickens BL, A Systematic Review of COVID-19 Epidemiology Based on Current Evidence.J Clin Med 2020;9(4):967 10.3390/jcm9040967

[2]

WHO. COVID-19 Dashboard..

[3]

Skiada A, Pavleas I, Drogari-Apiranthitou M, Epidemiology and Diagnosis of Mucormycosis: An Update.J Fungi 2020;6(4):265 10.3390/jof6040265

[4]

..

[5]

Talmi YP, Goldschmied-Reouven A, Bakon M, Barshack I, Wolf M, Horowitz Z, Rhino-Orbital and Rhino-Orbito-Cerebral Mucormycosis.Otolaryngol Head Neck Surg 2002;127(1):22-31 10.1067/mhn.2002.126587

[6]

Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing

Timothy M Rawson, Luke S P Moore, Nina Zhu et al.

Clinical Infectious Diseases 10.1093/cid/ciaa530

[7]

Chander J, Kaur M, Singla N, Punia R, Singhal S, Attri A, Mucormycosis: Battle with the Deadly Enemy over a Five-Year Period in India.J Fungi 2018;4(2):46 10.3390/jof4020046

[8]

Tugsel Z, Sezer B, Akalin T, Facial swelling and palatal ulceration in a diabetic patient.Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:630-6 10.1016/j.tripleo.2004.07.006

[9]

Leitner C, Hoffmann J, Zerfowski M, Reinert S, Mucormycosis: necrotizing soft tissue lesion of the face.J Oral Maxillofac Surg 2003;61(11):1354-8 10.1016/s0278-2391(03)00740-7

[10]

Gupta S, Goyal R, Kaore NM, Rhino-Orbital-Cerebral Mucormycosis: Battle with the Deadly Enemy.Indian J Otolaryngol Head Neck Surg 2020;72(1):104-11 10.1007/s12070-019-01774-z

[11]

Auluck A, Maxillary necrosis by mucormycosis A case report and literature review.Med Oral Patol Oral Cir Bucal 2007;12:360-4

[12]

Mehta S, Pandey A, Rhino-Orbital Mucormycosis Associated With COVID-19.Cureus 2020;12(9):10726 10.7759/cureus.10726

[13]

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Clinical and immunologic features in severe and moderate Coronavirus disease 2019.J Clin Invest.137244

[14]

Werthman-Ehrenreich A, Mucormycosis with orbital compartment syndrome in a patient with COVID-19.Am J Emerg Med 2021;42:264.e5-e8 10.1016/j.ajem.2020.09.032

[15]

Whoreafc-TW G, JAC Sterne, S Murthy, JV Diaz, AS Slutsky, J Villar, Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19 a meta-analysis.JAMA 2020;324(13):1330-41

[16]

Revannavar SM, PS Supriya, Samaga L, VK Vineeth, COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?.BMJ Case Rep 2021;14(4):e241663 10.1136/bcr-2021-241663

[17]

WM Khatib, SV Jagtap, PM Patel , Tonsillar actinomycosis – A case report.Int J Health Sci Res 2015;5(9):607-9

[18]

Song G, Liang G, Liu W, Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China.Mycopathologia 2020;185:599-606 10.1007/s11046-020-00462-9

[19]

Patel A., Kaur H., Xess I., Michael J.S., Savio J., Rudramurthy S., A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.Clin Microbiol Infect 2020;26(7):944.e9-e15 10.1016/j.cmi.2019.11.021

[20]

Jeong Wirawan, Keighley Caitlin, Wolfe Rory, Lee Wee Leng, Slavin Monica A., Chen Sharon C-A., Kong David C.M., Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.International Journal of Antimicrobial Agents 2019;53(5):589-597 10.1016/j.ijantimicag.2019.01.002

[21]

Maini A, Tomar G, Khanna D, Kini Y, Mehta H, Bhagyasree V, Sino-orbital mucormycosis in a COVID-19 patient: A case report.Int J Surg Case Rep 2004;82:105957 10.1016/j.ijscr.2021.105957

[22]

Garg D, Muthu V, Sehgal I S, Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.Mycopathologia 2021;186(2):289-98 10.1007/s11046-021-00528-2

Metrics

12

Citations

22

References

Details

Published: May 15, 2021
Vol/Issue: 6(2)
Pages: 135-139

Authors

Cite This Article

Sunil V Jagtap, Swati S Jagtap, Vaidehi Nagar, et al. (2021). Invasive mucormycosis in post COVID-19 infection: Case report with review. IP Archives of Cytology and Histopathology Research, 6(2), 135-139. https://doi.org/10.18231/j.achr.2021.033

Invasive mucormycosis in post COVID-19 infection: Case report with review

You May Also Like